Healthcare -
Biotechnology - NASDAQ - US
$ 0.8238
-0.627 %
$ 2.28 M
Market Cap
-0.06
P/E
PALI - COST OF REVENUE
Cost of Revenue PALI - Palisade Bio, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR